THOMAS SERIO: Open Payments
NPI 1184654055 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 20 payments from 11 companies in 2025. Trend: 2023 $593 · 2024 $380 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $77 |
| IBSA Pharma Inc. | 3 | $67 |
| SCILEX PHARMACEUTICALS INC. | 3 | $53 |
| Lilly USA, LLC | 2 | $50 |
| PFIZER INC. | 2 | $43 |
| Almatica Pharma LLC | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
Products named: Ozempic, Tirosint, ZTLido, KISUNLA, PREVNAR 20, TERIPARATIDE, REXULTI, Sunosi.
Industry payments across FL — which companies pay providers there.
